+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Pediatric Neuroblastoma - Pipeline Insight, 2024 - Product Thumbnail Image

Pediatric Neuroblastoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Peritoneal Carcinomatosis (PC) - Pipeline Insight, 2024 - Product Thumbnail Image

Peritoneal Carcinomatosis (PC) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Primary myelofibrosis - Pipeline Insight, 2024 - Product Thumbnail Image

Primary myelofibrosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 150 Pages
  • Global
From
Prostate Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Prostate Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Recurrent Glioblastoma - Pipeline Insight, 2024 - Product Thumbnail Image

Recurrent Glioblastoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 200 Pages
  • Global
From
Tenosynovial Giant Cell Tumors - Pipeline Insight, 2024 - Product Thumbnail Image

Tenosynovial Giant Cell Tumors - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Testicular Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Testicular Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Transitional Cell Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Transitional Cell Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Triple Negative Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Triple Negative Breast Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 230 Pages
  • Global
From
Urothelial Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Urothelial Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 170 Pages
  • Global
From
Cervical Intraepithelial Neoplasia - Pipeline Insight, 2024 - Product Thumbnail Image

Cervical Intraepithelial Neoplasia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Small Lymphocytic Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Small Lymphocytic Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 200 Pages
  • Global
From
Soft Tissue Neoplasms - Pipeline Insight, 2024 - Product Thumbnail Image

Soft Tissue Neoplasms - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Lip and Oral Cavity Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Lip and Oral Cavity Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Liver Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Liver Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 240 Pages
  • Global
From
From
Malignant Melanoma - Pipeline Insight, 2024 - Product Thumbnail Image

Malignant Melanoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Merkel Cell Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Merkel Cell Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Mesothelioma - Pipeline Insight, 2024 - Product Thumbnail Image

Mesothelioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 210 Pages
  • Global
From
Metastatic HER2 positive breast cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic HER2 positive breast cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more